HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pavel Bogomolov Selected Research

myrcludex-B

1/2016Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pavel Bogomolov Research Topics

Disease

3Infections
12/2023 - 01/2016
3Chronic Hepatitis D
07/2023 - 01/2016
2Chronic Hepatitis (Chronic Active Hepatitis)
05/2024 - 01/2016
2Fibrosis (Cirrhosis)
07/2023 - 01/2023
1Coinfection
01/2023
1Virus Diseases (Viral Diseases)
01/2023
1Hepatitis D
01/2016
1Chronic Hepatitis B
01/2016
1Hepatitis B
01/2016

Drug/Important Bio-Agent (IBA)

3bulevirtideIBA
05/2024 - 01/2023
1Anti-Bacterial Agents (Antibiotics)IBA
12/2023
1Proton Pump InhibitorsIBA
12/2023
1Dihydrotachysterol (AT 10)IBA
07/2023
1RNA (Ribonucleic Acid)IBA
07/2023
1Tenofovir (Viread)FDA Link
01/2023
1Interferon-alpha (Interferon Alfa)IBA
01/2016
1myrcludex-BIBA
01/2016
1InterferonsIBA
01/2016

Therapy/Procedure

1Contraindications
01/2023